Premix insulin regimens haffizabad 22 02 2012
-
Upload
maqsood-mehmood -
Category
Health & Medicine
-
view
873 -
download
0
description
Transcript of Premix insulin regimens haffizabad 22 02 2012
![Page 1: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/1.jpg)
In the Name of ALLAH, Ever Beneficent, Infinitely Merciful
![Page 2: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/2.jpg)
04/11/2304/11/23 22
![Page 3: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/3.jpg)
04/11/2304/11/23 33
![Page 4: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/4.jpg)
04/11/23 4
![Page 5: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/5.jpg)
HOW TO DIAGNOSEHOW TO DIAGNOSEDIABETES?DIABETES?
04/11/2304/11/23 55
![Page 6: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/6.jpg)
TREATMENT TARGETSTREATMENT TARGETS
04/11/2304/11/23 66
![Page 7: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/7.jpg)
Efficacy of Monotherapy in Type 2 Diabetes
Agent HbA1c reduction %
Fasting glucose
Reduction (mg/dl)
Sulphonylurea 1.5 - 2.0 60 - 80
Metformin 1.5 - 2.0 60 - 80
Pioglitazone 0.6 - 1.9 50 - 80
Alpha Gucosidase inhibitor
0.5 - 1.0 20 - 30
Bonnie Kimmel, MD and Silvio E. Inzucchi, MD Clinical Diabetes 23:64-76, 200504/11/2304/11/23 77
![Page 8: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/8.jpg)
Current FDA Approved
Combination Therapy Options in Type 2 Combination Additional
Lowering of HbA1c
Additional Lowering of FBG
(mg/dl)
SU + MTF 1.5 – 2.0 60 – 80
SU + TZD 1.0 – 1.5 40 – 60
MTF + TZD 0.6 – 0.8 20 – 40
SU + AGI 1.0 – 1.5 20 – 40
Bonnie Kimmel, MD and Silvio E. Inzucchi, MD Clinical Diabetes 23:64-76, 2005
04/11/2304/11/23 88
![Page 9: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/9.jpg)
Mazze, Strock, Simonson, Kendall, Cuddihy, Bergenstal. SDM Quick Guide 5th Edition, International Diabetes Center, 2009
Staged DiabetesManagement at IDC
*
04/11/2304/11/23 99
![Page 10: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/10.jpg)
Stages of Type 2 Diabetes—Stages of Type 2 Diabetes—UKPDSUKPDS
-C
ell
Funct
ion (
%)
PostprandialHyperglycemia
IGT Type 2DiabetesPhase I Type 2
DiabetesPhase II
Type 2 DiabetesPhase III
25
100
75
0
50
-12 -10 -6 -2 0 2 6 10 14
Years From Diagnosis
Lebovitz H. Diabetes Review. 1999;7:139.04/11/2304/11/23 1010
![Page 11: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/11.jpg)
04/11/2304/11/23 1111
![Page 12: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/12.jpg)
04/11/2304/11/23 1212
![Page 13: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/13.jpg)
Patient J.L., December 15, 1922 Februray 15, 1923
The Miracle of The Miracle of InsulinInsulin
04/11/23 13
![Page 14: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/14.jpg)
Adapted from Stratton IM, et al. UKPDS 35. BMJ 2000; 321:405–412.
UKPDS: decreased risk of diabetes-related complications UKPDS: decreased risk of diabetes-related complications associated with a 1% decrease in A1Cassociated with a 1% decrease in A1C
UKPDS: decreased risk of diabetes-related complications UKPDS: decreased risk of diabetes-related complications associated with a 1% decrease in A1Cassociated with a 1% decrease in A1C
Per
cen
tag
e d
ecre
ase
in r
ela
tive
ris
k co
rres
po
nd
ing
to
a 1
% d
ecre
ase
in H
bA
1C
**
Any diabetes-related endpoint
21%
**
Diabetes-related death
21% **
All cause
mortality
14%*
Stroke
12%
**
Peripheral vascular disease†
43%
**
Myocardial infarction
14%
**
Micro-vascular disease
37%
**
Cataract extraction
19%
Observational analysis from UKPDS study data
†Lower extremity amputation or fatal peripheral vascular disease*P = 0.035; **P < 0.0001
04/11/2304/11/23
1414
![Page 15: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/15.jpg)
“The Magnificent Seven”
When should Insulin be used in When should Insulin be used in Type 2 diabetes mellitus?Type 2 diabetes mellitus?
04/11/2304/11/23 1616
![Page 16: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/16.jpg)
1. Type 2 diabetes not controlled with maximal doses of Oral Hypoglycaemic agents
What do you mean by maximal doses of OHAs?
Metformin 2500/3000mg a day
+
Glipizide 20mg/glibenclemide15-20mg/day
Gliciazide 320mg/ Glimepride 6-8mg/day
+
Rosiglitazone 8mg/ Pioglitazone 45mg/day
When should Insulin be used in When should Insulin be used in Type 2 diabetes mellitus?Type 2 diabetes mellitus?
04/11/2304/11/23 1717
![Page 17: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/17.jpg)
2. Type 2 diabetes during periods of physiological
stress (surgery, infection)
Continue OHAs simultaneously.
Stop metformin in case of severe infections or
impending reduction in renal perfusion
When should Insulin be used in When should Insulin be used in Type 2 diabetes mellitus?Type 2 diabetes mellitus?
04/11/2304/11/23 1818
![Page 18: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/18.jpg)
04/11/2304/11/23 1919
![Page 19: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/19.jpg)
04/11/2304/11/23 2020
![Page 20: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/20.jpg)
04/11/2304/11/23 2121
![Page 21: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/21.jpg)
3. gestational diabetes
Metformin may be continued
Discontinue other medications
When should Insulin be used in When should Insulin be used in Type 2 diabetes mellitus?Type 2 diabetes mellitus?
04/11/2304/11/23 2222
![Page 22: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/22.jpg)
04/11/2304/11/23 2323
![Page 23: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/23.jpg)
4. Use of parenteral nutrition
or high-caloric supplements
Indications of Insulin therapy?Indications of Insulin therapy?
04/11/2304/11/23 2424
![Page 24: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/24.jpg)
5. Diabetic ketoacidosis (DKA)/Hyperosmolar
hyperglycemic nonketotic syndrome (HHNS)
Indications of Insulin therapy?Indications of Insulin therapy?
04/11/2304/11/23 2525
![Page 25: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/25.jpg)
6. Progressive complications:
proliferative retinopathy/maculopathy, progressive or painful neuropathy
For rapid control and tighter adjustment
Indications of Insulin therapy?Indications of Insulin therapy?
04/11/2304/11/23 2626
![Page 26: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/26.jpg)
7. Chronic Renal Failure
For all above a creatinine of 4.0mg/dl
Cutoffs for other OHAs:-
Metformin: 1.5mg/dl
Glimeperide/Glibenclemide: 2.0mg/dl
Glipizide: 2.5mg/dl
Pioglitazone/Rosiglitazone: 4.0mg/dl
Indications of Insulin therapy?Indications of Insulin therapy?
04/11/2304/11/23 2727
![Page 27: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/27.jpg)
Normal PancreasNormal Pancreas
Insulin is released in response to varying blood glucose levels and hypoglycemia does not occur
Insu
lin E
ffec
t
Basal Insulin (~0.5-1.0 U/hr)
‘Bolus’ Insulin (Meal Associated)
04/11/2304/11/23 2828
![Page 28: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/28.jpg)
How does one classify the types of insulin?How does one classify the types of insulin?
Generally classified according to peak effect and duration of action
Rapid acting/lispro /aspart/glulisine
Short acting: regular.
Intermediate acting: NPH.
Long acting(basal) lantus. /levimer.
Premixed:(30/70), (50/50), (75/25)04/11/2304/11/23 2929
![Page 29: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/29.jpg)
Re
lati
ve
Ins
ulin
Eff
ec
tR
ela
tiv
e In
su
lin E
ffe
ct
Time (Hours)
0 2 4 6 8 10 12 14 16
Long-Acting: Glargine (Lantus®)Detemir (Levemir®)
18 20
Intermediate: NPH (Humulin® N, Novolin® N)
Short-Acting: Regular (Humulin® R, Novolin® R)
Rapid-Acting: Lispro (Humalog®), Aspart (NovoLog®),Glulisine (Apidra®)
Insulin Time Action Curves
Bergenstal, “Effective insulin therapy,” International Textbook of Diabetes Mellitus vol 1. 3rd ed, Chichester NY, John Wiley and Sons, Inc., 2004:995-1015. 04/11/23 31
![Page 30: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/30.jpg)
What are the types What are the types of insulin regimens?of insulin regimens?
• Premixed regimen
• Split mix regimen
• Basal bolus regime (multidose)
• Bedtime dosing alone (NPH/Lente/Glargine)
• Infusion
04/11/2304/11/23 3232
![Page 31: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/31.jpg)
Premixed insulinPremixed insulinAVAILABLE PREPRATIONSAVAILABLE PREPRATIONS • Premixed(30/70): Regular: 30 % NPH :
70%
• Premixed (50/50): lispro 50% NPL 50%
• Premixed Analogs Biphasic insulin aspart (30/70) 30% : Aspart 70% : protaminated aspart
04/11/2304/11/23 3333
![Page 32: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/32.jpg)
04/11/2304/11/23 3434
![Page 33: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/33.jpg)
04/11/2304/11/23 3535
![Page 34: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/34.jpg)
04/11/23 36
![Page 35: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/35.jpg)
Basic Insulin Regimen: Basic Insulin Regimen: Split-Mixed Regimen or Split-Mixed Regimen or
PremixPremix
Regular
NPH
B DL HS B
Endogenous insulin
04/11/2304/11/23 3737
![Page 36: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/36.jpg)
Basic Insulin Regimen: Basic Insulin Regimen: Split-Mixed Regimen or Split-Mixed Regimen or
PremixPremix• Does not
mimic normal physiology
• Requires meal consistency
• Snacking may result in weight gain
• Hypo- and hyperglycemia
Regular
NPH
B DL HS B
Endogenous insulin
Hyperglycemia
04/11/2304/11/23 3838
![Page 37: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/37.jpg)
Insulin Therapy RegimensInsulin Therapy Regimens
Usual starting dose: 0.5-1.0 unit/kg/day
04/11/2304/11/23 3939
![Page 38: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/38.jpg)
Premixed insulinPremixed insulin
• Dose adjustment:
• The fasting sugar depends on the night dose of insulin • The post breakfast sugar depends on the
morning dose of insulin
• Rough calculation increase the insulin by one unit to reduce the sugars by 25mg/dl
04/11/2304/11/23 4040
![Page 39: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/39.jpg)
Self Monitoring is crucialSelf Monitoring is crucial
Glucometers
At least 6-8 times a week ideally
04/11/2304/11/23 4141
![Page 40: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/40.jpg)
Premixed insulinPremixed insulin Advantages • more accurate dosing
• lesser injections
• Pen devices administer premixed forms
Disadvantages • Fine tuning may not be possible
• Strict meal pattern
• Nocturnal hypoglycemia
• May need “diet changes for insulin” rather than “insulin changes for diet”
04/11/2304/11/23 4242
![Page 41: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/41.jpg)
TIMING OF INJECTIONTIMING OF INJECTION
• 70/30 30 MINUTES BEFORE BREAKFAST AND SUPPER
• NOVO MIX 70/30
• HUMALOG MIX 25/75 5—15 MINUTES
• BEFORE BREAKFAST AND SUPPER
04/11/2304/11/23 4444
![Page 42: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/42.jpg)
ADVANTAGESADVANTAGES
• SIMPLE AND EASY TO USE ;draw A SINGLE DOSE OF A COMBINATION OF INSULIN IN ONE SYRINGE
• MINIMUM INSULIN DOSING THAT PROVIDES 24-HOUR INSULIN COVERAGE
• HUMALOG MIX 75/25 INSULIN OR NOVO MIX 70/30 INSULIN CAN BE TAKEN 5-15 MINUTES BEFORE A MEAL
04/11/2304/11/23 4545
![Page 43: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/43.jpg)
DISADVANTAGESDISADVANTAGES
• 70/30 INSULIN ;SHOULD WAIT 30 MINUTES AFTER INSULIN INJECTION BEFORE EATING THE MEAL
• FIXED RATIO OF INTERMEDIATE AND SHORT OR RAPID ACTING INSULIN MAY NOT CONTROL BLOOD GLUCOSE LEVELS
• CAN NOT ADJUST INTERMEDIATE-ACTING INSULIN COMPONENT WITHOUT ADJUSTING THE SHORT OR RAPID ACTING INSULIN COMPONENT
04/11/2304/11/23 4646
![Page 44: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/44.jpg)
DISADVANTAGESDISADVANTAGES
• CAN NOT ADJUST REGULAR INSULIN,INSULINASPART, OR INSULIN LISPRO FOR VARIATION IN FOOD INTAKE, BLOOD GLUCOSE LEVELS OR EXERCISE
• MUST TAKE INSULIN AND EAT MEALS ABOUT THE SAME TIME EVERY DAY MUST EAT ACONSISTANT AMOUNT OF CARBOHYDRATES AT EACH MEAL FROM DAY TO DAY
• LEAST FLEXABLE OF ALL REGIMENS
04/11/2304/11/23 4747
![Page 45: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/45.jpg)
INDICATIONSINDICATIONS
• PATIENTS WITH LIMITED CAPABILITIES
• PATIENTS WHO ARE UNWILLING TO INTENSIFY REGIMEN
• INITIAL REGIMEN AFTER DIAGNOSES TO LEARN AND ADAPT TO INJECTIONS
• TYPE 2 DIABETES04/11/2304/11/23 4848
![Page 46: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/46.jpg)
04/11/2304/11/23 4949
![Page 47: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/47.jpg)
STARTING DOSESTARTING DOSE
• 2/3 TOTAL DAILY DOSE BEFORE BREAKFAST ,1/3 TOTAL DAILY DOSE BEFORE SUPPER
• 0.5—1.0 U/KG/DAY
04/11/2304/11/23 5050
![Page 48: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/48.jpg)
Pre-mix (Pre-mix (70/3070/30))• Gaps in insulin coverage
• Poor long-term control
• Failure to match endogenous secretion pattern
• Dawn phenomenon
• Increased glycaemia
04/11/2304/11/23 5151
![Page 49: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/49.jpg)
Can Oral hypoglycaemic agents
be continued at the same time with insulin?
• Metformin Best continued if renal function is normal. May
reduce insulin requirements by 15-30%.• Adjunctive weight reducing effect
• Thiazolidinediones • May be continued with insulin. • Can reduce insulin requirements from 15-60% • Major issue of weight gain, accentuated by
insulin: 7.5%. 15%>5kg.
04/11/2304/11/23 5252
![Page 50: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/50.jpg)
Can Oral hypoglycaemic agents
be continued at the same time with insulin?
• Sulphonylureas
• Glimeperide: doses of 2-4mg a day have a peripheral GLUT-4 activity reducing insulin requirement by 10-20%.
• Glipizide and Glibenclemide can reduce insulin requirements by 5-15%.
• Unpredictable- recommended previously in those with high C-peptide levels
04/11/2304/11/23 5353
![Page 51: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/51.jpg)
Insulin administration is suitably as premixed fashion for Insulin administration is suitably as premixed fashion for most type 2 diabetes. Split-mix may be required in a most type 2 diabetes. Split-mix may be required in a subset. subset.
The neccessity of self blood glucose monitoring as a The neccessity of self blood glucose monitoring as a accessory is emphasized. accessory is emphasized.
Summarizing……..Summarizing……..
04/11/2304/11/23 5454
![Page 52: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/52.jpg)
Aggressively Titrated Premix
70/30+Met+Pio Met+Pio
Baseline A1C 8.1±1.0 7.9±0.9
EOS A1C 6.5±1.0 7.8±1.2
Percentage of Patients With A1C (EOS)
<7.0% 76.3 24.1
≤6.5 59.1 11.5
≤6.0 33.3 2.3
≤5.5 14.0 0
FPG (mg/dl) 130±50 162±41
Raskin et al. Insulin 2007;2 (suppl A):S1104/11/23 55
![Page 53: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/53.jpg)
Comparison of Common Insulin Regimens*
Variable Glargine* NPH1 Premix2,3 Detemir4
Efficacy Insulin Works
Hypoglycemia† 1.0 1.4X 2.5-5.0X 1.0
Insulin Dose 1.0 1.0 1.5-2.0X 1.6-2.1X
Weight Gain 1.0 1.0 1.5X 0.7-1.0X
*Normalized to glargine; sponsored comparator trials †Confirmed hypoglycemia1Riddle MC et al. Diabetes Care 2003;26:3080-3086 2Janka HU et al. Diabetes Care 2005;28:254-259 3Raskin P et al. Diabetes Care 2005;28:260-265 4Rosenstock J et al. ADA 2006; Abstract 555-P
04/11/23
56
![Page 54: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/54.jpg)
Tuesday, April 11, 2023
57
![Page 55: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/55.jpg)
04/11/2304/11/23 5858
![Page 56: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/56.jpg)
04/11/2304/11/23 DR MAXUD DIABETOLOGISTDR MAXUD DIABETOLOGIST 5959
![Page 57: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/57.jpg)
04/11/23 60
![Page 58: Premix insulin regimens haffizabad 22 02 2012](https://reader036.fdocuments.net/reader036/viewer/2022062418/554b38d5b4c905ff268b4628/html5/thumbnails/58.jpg)
04/11/23
61